Posted on

Health Effects Of Pollution In The Air At ERS 2018

Research focused on long-term health problems after exposure to pollution will be in the spotlight at the upcoming European Respiratory Society (ERS) International Congress 2018. Mina Gaga “There are quite a lot of interesting data coming out about pollution and the lungs,” said ERS President Mina Gaga, MD, PhD, from Athens Chest Hospital in Greece.…

Read more

Posted on

Cancer Patient Other Victim of Yemen’s War

SANAA/HODEIDAH, Yemen (Reuters) – On Yemen’s western coast, Mohammed al-Hosami receives support from the people of his village in al Mahwit to pay for his mother’s cancer treatment in a clinic in nearby Hodeidah city. “There is no work or salary so we can’t afford transportation costs, and the village helped me with the payments…

Read more

Posted on

Compare Harvoni vs. Epclusa

Harvoni (ledipasvir / sofosbuvir) Myhep Lvir, Hepcinat, Ledihep, etc Epclusa (velpatasvir / sofosbuvir) Mylan All, Velpanat, Sovihep, Resof, etc. Treats hepatitis C. Harvoni (ledipasvir / sofosbuvir) is a combination pill for hepatitis C that you only need to take once a day. Depending on the amount of liver damage you have, it’s sometimes taken together…

Read more

Posted on

Did They Die Of Prostrate Cancer

An audit of death certificates from Norway has found that one third of all deaths attributed to prostate cancer were actually caused by something else. However, there was also an underreporting of prostate deaths in the study — wherein some men who were reported to have died of other causes were considered by the researchers…

Read more

Posted on

Four Treatment For Mastectomy Pain,But ‘No Magic Drug’.

Postmastectomy pain syndrome is a “major clinical challenge,” but four treatment modalities have been found to have a “significant effect” on the pain, conclude the authors of a new review systematic review of the subject. However, another expert laid emphasis elsewhere, saying there is “no magic drug” and that some patients feel their ongoing, intractable…

Read more

Posted on

Aspirin Plus PPI Prevents Esophageal Cancer.

Combined use of aspirin and a high-dose proton pump inhibitor (PPI) protects against the development of esophageal cancer in people who are at elevated risk for the malignancy, according to the results of a major phase 3 chemoprevention trial from the United Kingdom, the Aspirin and Esomeprazole Chemoprevention in Barrett’s Metaplasia (AspECT) trial. Dr Janusz…

Read more

Posted on

Combo Of RT And Chemotherapy: Best For Early FL

For the management of early-stage follicular lymphoma (FL), a randomized trial shows that the combination of radiotherapy (RT) with chemo immunotherapy gives better clinical outcomes that treatment with radiation alone, and the researchers reporting these results say that they should change clinical practice. After a median follow-up of 9.6 years, the estimated 10-year progression-free survival…

Read more

Posted on

Drug Combination Shows Promise In Advanced Prostrate Cancer.

Adding the poly ADP ribose polymerase (PARP) inhibitor olaparib (Lynparza, AstraZeneca) to the androgen synthesis inhibitor abiraterone acetate (Zytiga, Janssen) significantly improves progression-free survival (PFS) in men with advanced prostate cancer over abiraterone alone, UK researchers have discovered. Studying 142 patients with metastatic castration-resistant prostate cancer (mCRPC), Dr Noel Clarke, The Christie and Salford Royal…

Read more

Posted on Leave a comment

Uveal Melanoma: Better Survival With Liver Directed Therapy.

  For patients with uveal melanoma, the most common eye cancer in adults, survival outcomes have improved in recent years, after treatment modalities shifted from systemic to liver-directed therapies. The finding comes from researchers at the Thomas Jefferson University in Philadelphia, Pennsylvania, and was presented at the recent American Society of Clinical Oncology (ASCO) 2018…

Read more

Posted on Leave a comment

FDA Approves Pegfilgrastim Biosimilar for Cancer Infection Risk

Author: Nick Mulcahy The U.S. Food and Drug Administration has approved the first biosimilar to pegfilgrastim (Neulasta, Amgen), a granulocyte colony-stimulating factor used to reduce infection risk in patients with cancer. The new product is pegfilgrastim-jmdb ( Fulphila , Mylan GmbH), approved for use to decrease the risk for infection in patients with nonmyeloid cancer who are receiving…

Read more

Posted on Leave a comment

GDMeds.com explore a new way to serve the people

India’s Trusted Pharmacy: Purchase Cancer Drugs Online in India No more running from one chemist store to another when in need of medicines! GDMeds.com brings to you an online medicine store, which can be accessed for all health needs. We are focused towards making healthcare accessible and affordable, especially for cancer drugs, such as chemotherapy,…

Read more